Surface Nerve Stimulation Treatment for OAB in Children

Sponsor
University of Aarhus (Other)
Overall Status
Completed
CT.gov ID
NCT00282490
Collaborator
(none)
30
1
24.9
1.2

Study Details

Study Description

Brief Summary

The purpose of this study is to perform a randomized controlled investigation of the effect of surface nerve stimulation on functional daytime incontinence in children with OAB.

Condition or Disease Intervention/Treatment Phase
  • Device: Nerve stimulator
N/A

Detailed Description

Daytime urinary incontinence is common in children. At the age of 7 a prevalence of 2-9 % has been reported. Daytime urinary incontinence is a heterogenic multifactorial illness where the the symptoms has several degrees of severity and can be caused by different mechanisms. Daytime urinary incontinence can be etiologically classified in the rare neurogenic and structural forms and the common functional or idiopathic form (where no neurological or structural cause of the bladder dysfunction can be identified.

The symptom based diagnosis OAB (overactive bladder) is most often used to describe daytime urinary incontinence in children. OAB is defined as a symptom syndrome including urgency with or without urge incontinence in combination with frequency.

When urinary tract infection and neurogenic and structural causes has been excluded the nonpharmacological bladder rehabilitation is first line treatment of OAB. It is expected that approximately 50 % of the children can be relieved of symptoms by this treatment. In the non-responding cases behavioural modifying regimes can be coupled with anticholinergic medication. However, poor compliance of the child or parents, or dose limiting side effects often influences the efficacy of this intervention. Also a considerable number of children experience no or only limited effect from the treatment even though all instructions are complied with. This has let to research into new treatment modalities and the use of low frequency electrical current to inhibit detrusor overactivity in adults has become common. Pilot studies have indicated a significant effect of TENS on urinary incontinence in children with OAB.

Hypothesis:
  • Sacral TENS is an effective treatment of urinary incontinence in children with OAB refractory to anticholinergic medication coupled with bladder training and voiding reeducation.

  • The acute effect of sacral TENS can be identified by urodynamics

  • It is possible to predict the outcome of sacral TENS treatment in these children.

30 children (age 5-14 years) with functional daytime incontinence refractory to anticholinergic medication coupled with bladder training. The study protocol consists of 1 week of basic home registrations and a 4 day in-patient phase succeeded by a 4 week home training period. The participants will be randomized to treatment with either active or inactive TENS.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Sacral Transcutaneous Nerve Stimulation Treatment for Functional Daytime Incontinence in Children With Over Active Bladder Syndrome
Study Start Date :
Feb 1, 2006
Actual Primary Completion Date :
Mar 1, 2008
Actual Study Completion Date :
Mar 1, 2008

Outcome Measures

Primary Outcome Measures

  1. Clinical effects evaluated by home registrations of degree of incontinence, VAS score of degree of urgency and frequency volume charts at specified intervals. Acute effect evaluated by urodynamics. []

Secondary Outcome Measures

  1. Bladder capacity, voiding frequency and subjective impression of incontinence. []

Eligibility Criteria

Criteria

Ages Eligible for Study:
5 Years to 15 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Daytime urinary incontinence with at least 1 episode of at least 1 ml per week

  • Incontinence refractory to treatment

  • Informed consent

Exclusion Criteria:
  • Severe diseases of the kidneys or urinary tract besides OAB

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of pediatrics,Skejby Sygehus, University hospital of Aarhus Aarhus Aarhus N Denmark 8200

Sponsors and Collaborators

  • University of Aarhus

Investigators

  • Principal Investigator: Soeren Hagstroem, MD, University of Aarhus

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00282490
Other Study ID Numbers:
  • SHTENS2006
  • 2006-41-6085,
  • 20050180
First Posted:
Jan 26, 2006
Last Update Posted:
Jun 17, 2008
Last Verified:
Jun 1, 2008
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 17, 2008